[Clinical assessment of isoprenaline sulfate aerosol as compared to Astmopent].
D000336:Aerosols; D000368:Aged; D001249:Asthma / Q000188:drug therapy; D001991:Bronchitis / Q000188:drug therapy; D005260:Female; D006321:Heart / Q000187:drug effects*; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007545:Isoproterenol / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D008297:Male; D009921:Metaproterenol / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D008875:Middle Aged; D013431:Sulfates / Q000494:pharmacology
D000336:Aerosols; D013431:Sulfates; D009921:Metaproterenol; D007545:Isoproterenol
Ocena kliniczna aerozolu siarczanu izoprenaliny i badania porównawcze z Astmopentem